CHASIDY MARQUIS: Open Payments
NPI 1689096166 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,022 in 99 payments from 12 companies in 2025. Trend: 2023 $1,933 · 2024 $2,200 · 2025 $2,022
Food & beverage: $1,862Education: $160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $608 |
| UCB, Inc. | 13 | $286 |
| E.R. Squibb & Sons, L.L.C. | 13 | $207 |
| Janssen Biotech, Inc. | 26 | $198 |
| Regeneron Healthcare Solutions, Inc. | 8 | $161 |
| Novartis Pharmaceuticals Corporation | 7 | $159 |
| Amgen Inc. | 6 | $124 |
| REVANCE THERAPEUTICS, INC. | 2 | $105 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $80 |
| Organon LLC | 4 | $62 |
Products named: BOTOX, Bimzelx, Sotyktu, TREMFYA, DUPIXENT, OTEZLA, DAXXIFY, SKYRIZI.
Industry payments across TX — which companies pay providers there.
